The Biomedical Sciences Research Center “Alexander Fleming” (FLEMING) is the top-ranked research center in the Life Sciences in Greece. FLEMING has gained international recognition for its pioneering research towards understanding the molecular basis of human diseases, such as autoimmune disorders, cancer, neurodegeneration and osteoporosis, and the development of new approaches for their diagnosis and treatment. The Centre’s major goal for the coming years is to support excellent research with a focus on innovation. In this direction, FLEMING has recently established the new Institute of Bio-Innovation with a mission to advance basic research discoveries towards innovation in the areas of biotechnology and drug discovery and convert them to tangible outcomes for the economy and the society. Furthermore, FLEMING has planned the establishment of the national R&I infrastructure “Biotechnopolis”, the first integrated Biotechnology hub in Greece and the wider region, to foster the development of innovative biomedical, biotechnological and pharmaceutical products and technologies through the creation of a fertile environment offering access to excellent research, high-end infrastructures and a culture of entrepreneurship close to academia. The goal of Boost4Bio is to attract and maintain an exceptional researcher and innovator in Biomolecular Engineering & Synthetic Biology to establish a new excellent team at FLEMING, promote the integration of basic and applied research, boost bio-innovation and bio-entrepreneurship at the Center, and lead the establishment of “Biotechnopolis”. Boost4Bio will have a major impact on the promotion of excellence in biomedical research, training and innovation in Greece, will support the proper establishment of a new and unique Excellence Unit in Greece and the wider region, and will contribute to the creation of new career prospects and the prevention of the brain drain phenomenon, which is particularly acute in this area of the Union.
